Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 10

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 10
---
 Voting Allowed |
| Proposal 1 – Election of Three Class III Directors                                                                     |     | Majority of the votes cast                                                                                                      |     | No             |
| Proposal 2 – Ratification of the Appointment of Ernst & Young LLP as our Independent Registered Public Accounting Firm |     | Majority of the voting power of the shares present virtually or represented by proxy and entitled to vote on the subject matter |     | Yes            |
| Proposal 3 – Advisory Vote on Approval of Executive Compensation                                                       |     | Majority of the voting power of the shares present virtually or represented by proxy and entitled to vote on the subject matter |     | No             |
| Proposal 4 – Increase in the Number of                                                                                 
 Shares of Common Stock Authorized for Issuance Under the 2020 Equity Incentive Plan                                    |     | Majority of the voting power of the shares present virtually or represented by proxy and entitled to vote on the subject matter |     | No             |

With respect to Proposal 1, you may vote FOR a nominee, AGAINST a nominee, or ABSTAIN from voting on a nominee. A nominee will be elected if the votes cast for such nominee’s election exceed the votes cast against such nominee’s election. You may not cumulate votes in the election of directors. If any incumbent nominee receives a greater number of votes AGAINST his or her election than votes FOR such election, our corporate governance guidelines require that such incumbent nominee tender his or her resignation promptly following certification of the applicable stockholder vote. The Qualified Independent Directors (as defined in the corporate governance guidelines) will then decide whether to accept or reject the resignation or whether other action should be taken. Our Board of Directors, through the Qualified Independent Directors, will publicly disclose its decision and the rationale behind it within 90 days from the date the election results are certified. Full details of this policy are set forth in our corporate governance guidelines on our website at https://investor.pacificbiosciences.com , under “Corporate Governance — Governance Overview.” If you ABSTAIN from voting on a nominee, the abstention will not be counted as a vote “FOR” or “AGAINST” such nominee’s election and will not have an effect on the outcome of the vote.

With respect to Proposal 2, you may vote FOR, AGAINST or ABSTAIN. If you ABSTAIN from voting on this proposal, the abstention will have the same effect as a vote AGAINST such proposal. Because this is a routine proposal, we do not anticipate any broker non-votes on